CLOV (Clover Health Investments) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)

What is Clover Health Investments LT-Debt-to-Total-Asset?

Clover Health Investments CLOV +3.64% 81 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus rates CLOV with a GF Score™ of 81/100 and a GF Value™ of $3.96 (Significantly Overvalued). The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Clover Health Investments's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Clover Health Investments's long-term debt to total assets ratio stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Clover Health Investments (NAS:CLOV) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Clover Health Investments LT-Debt-to-Total-Asset Related Terms

Clover Health Investments LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Clover Health Investments's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments LT-Debt-to-Total-Asset Chart

Clover Health Investments Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.03

0.01

0.00

Clover Health Investments Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

81GF Score

Clover Health Investments Corp CLOV

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Clover Health Investments LT-Debt-to-Total-Asset Calculation

Clover Health Investments's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	0	/	541.011
	=	0.00

Clover Health Investments's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	0	/	697.728
	=	0.00

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.00 mean?

Clover Health Investments (CLOV) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Clover Health Investments and its competitors.

Is Clover Health Investments' LT-Debt-to-Total-Asset too high?

Clover Health Investments' current LT-Debt-to-Total-Asset is 0.00. Overall, Clover Health Investments has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Clover Health Investments' LT-Debt-to-Total-Asset compare to PGNY and ALHC?

Clover Health Investments' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Healthcare Plans company?

A good LT-Debt-to-Total-Asset depends on the Healthcare Plans industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Clover Health Investments and its competitors. Clover Health Investments's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Clover Health Investments stock overvalued right now?

Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.96, compared to a current price of $5.41 — trading 36.6% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Clover Health Investments' overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (CLOV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of $5.41 is trading 36.6% above its estimated GF Value™ of $3.96. GuruFocus considers Clover Health Investments to be Significantly Overvalued.

Key valuation signals for CLOV:

LT-Debt-to-Total-Asset: 0.00
GF Value™: $3.96 vs. price of $5.41 (36.6% above fair value)
GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Health Investments Business Description

Industry Healthcare Healthcare Plans

Comparable Companies PGNY ALHC PFHO OSCR MOH UNH CVS ELV CI HUM CNC BSP:SAUD3 SZSE:000503 NSE:MEDIASSIST BJSE:920656 BSP:QUAL3 ROCO:6665

Other Exchanges 7QD:Germany CLOV34:Brazil

Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067

Website https://www.cloverhealth.com

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

81GF Score

Get the complete analysis for CLOV

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.41

Price

$3.96

GF Value

View CLOV Analysis

See LT-Debt-to-Total-Asset data for all stocks →